Intra-Cellular Therapies
ITCI
#1267
Rank
S$18.88 B
Marketcap
$177.25
Share price
0.05%
Change (1 day)
92.45%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.17

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.16. In 2022 the company made an earnings per share (EPS) of -$3.66 an increase over its 2021 EPS that were of -$4.70.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.17-40.75%
2022-$3.66-22.29%
2021-$4.708.02%
2020-$4.3520.9%
2019-$3.60-5.63%
2018-$3.8233.96%
2017-$2.85-21.19%
2016-$3.62-7.56%
2015-$3.91174.53%
2014-$1.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.34-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$13.44 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.88 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA